IRIS
GRAVINA, Antonietta Gerarda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.214
NA - Nord America 6.870
AS - Asia 4.915
SA - Sud America 733
Continente sconosciuto - Info sul continente non disponibili 326
AF - Africa 84
OC - Oceania 12
Totale 24.154
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.276
US - Stati Uniti d'America 6.666
SG - Singapore 1.747
IT - Italia 1.389
CN - Cina 1.040
IE - Irlanda 852
HK - Hong Kong 654
VN - Vietnam 605
BR - Brasile 585
GB - Regno Unito 362
DE - Germania 315
UA - Ucraina 287
KR - Corea 216
FR - Francia 154
IN - India 148
JP - Giappone 126
FI - Finlandia 121
BD - Bangladesh 117
SE - Svezia 103
CA - Canada 88
TR - Turchia 73
NL - Olanda 70
GR - Grecia 56
AT - Austria 53
AR - Argentina 50
PL - Polonia 44
ES - Italia 38
MX - Messico 38
IQ - Iraq 36
EC - Ecuador 27
PK - Pakistan 24
BE - Belgio 23
ZA - Sudafrica 22
CO - Colombia 21
ID - Indonesia 18
MA - Marocco 15
AZ - Azerbaigian 14
VE - Venezuela 14
PY - Paraguay 13
JM - Giamaica 12
AU - Australia 11
CR - Costa Rica 11
PH - Filippine 11
EE - Estonia 10
TT - Trinidad e Tobago 10
UZ - Uzbekistan 10
NI - Nicaragua 9
IR - Iran 8
LT - Lituania 8
PE - Perù 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
EG - Egitto 7
MY - Malesia 7
TH - Thailandia 7
AL - Albania 6
HN - Honduras 6
JO - Giordania 6
KE - Kenya 6
RO - Romania 6
SC - Seychelles 6
GT - Guatemala 5
PT - Portogallo 5
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
BS - Bahamas 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
OM - Oman 4
SN - Senegal 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AO - Angola 2
BF - Burkina Faso 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GE - Georgia 2
GP - Guadalupe 2
KH - Cambogia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 23.805
Salva come PNG Salva come JPEG
Città #
Moscow 2.598
San Jose 860
Dublin 844
Singapore 785
Santa Clara 686
Hong Kong 633
Ashburn 626
Chandler 442
Council Bluffs 424
Jacksonville 421
Naples 358
Seoul 212
Hefei 198
Ho Chi Minh City 192
Beijing 187
New York 146
Milan 143
Hanoi 138
Los Angeles 128
Princeton 113
Dallas 93
Munich 84
Roxbury 84
Bengaluru 78
Boardman 76
Ann Arbor 71
Cambridge 58
The Dalles 58
Rome 57
Medford 54
Bremen 53
Wilmington 50
North Bergen 47
Orem 44
São Paulo 44
Amsterdam 43
Woodbridge 41
Miano 40
Da Nang 38
Caserta 37
Chicago 36
San Francisco 36
Tokyo 34
Haiphong 32
Nuremberg 31
Vienna 29
Atlanta 26
Phoenix 26
Des Moines 24
Dong Ket 24
Kraków 24
San Mateo 24
Turku 24
Aversa 23
Paris 23
Brussels 22
Nanjing 22
Brooklyn 21
Helsinki 21
Houston 21
Montecorvino Rovella 19
Mountain View 19
Napoli 19
Montreal 18
Manchester 17
Duhok 16
Guangzhou 16
Warsaw 16
Boston 15
Boydton 15
Frankfurt am Main 15
Johannesburg 15
Kochi 15
London 15
Porto Alegre 15
Turin 15
Buffalo 14
Jinan 14
Mumbai 14
Shanghai 14
Baku 13
Charlotte 13
Memphis 13
Quito 13
Curitiba 12
Denver 12
Hải Dương 12
Mexico City 12
Miami 12
Ninh Bình 12
Shenyang 12
Bologna 11
Brasília 11
Lappeenranta 11
Seattle 11
Stockholm 11
Belo Horizonte 10
Biên Hòa 10
San José 10
Tashkent 10
Totale 12.354
Salva come PNG Salva come JPEG
Nome #
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 254
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity? 241
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 221
Intrafamilial spread of Helicobacter pylori infection 201
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 193
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 192
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 190
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 190
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 188
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 188
Dynamic shifts in lung cytokine patterns in post-COVID-19 interstitial lung disease patients: a pilot study 186
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 185
Crohn’s disease and skin 184
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 179
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 178
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 177
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 176
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 172
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 172
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 171
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 170
Apple polyphenols extract (APE) improves colon damage in a rat model of colitis 169
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 168
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 168
Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer 167
Global treatment of haemorrhoids-A worldwide snapshot audit conducted by the International Society of University Colon and Rectal Surgeons 166
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 165
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 165
Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin 163
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 162
CARDIAC PACEMAKER AND WIRELESS CAPSULE ENDOSCOPY INTERFERENCE: CASE REPORT IN A PATIENT WITH GASTRIC VASCULAR ECTASIAS 162
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 162
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 161
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 161
Comparison of Timing to Develop Anti-Drug Antibodies to Infliximab and Adalimumab Between Adult and Pediatric Age Groups, Males and Females 161
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 159
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 159
Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study 159
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 159
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 158
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 157
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 157
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 157
Ulcerative colitis associated with leukocytoclastic vasculitis of the skin 157
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 157
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 155
Apple polyphenol extracts prevent aspirin-induced damage to the rat gastric mucosa 154
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 153
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 153
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 153
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 153
Caso di interferenza tra video capsula e pacemaker in paziente portatore di pacemaker per aritmia 151
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 151
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 150
Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson 149
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 149
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 148
A randomized controlled trial of acarbose in hepatic encephalopathy 148
Light alcohol drinking and the risk of cancer development: a controversial relationship 148
Inflammatory Bowel Diseases: The Role of Gut Microbiota 148
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) 148
Endoscopic calcium electroporation for unfit-for-surgery bleeding colorectal cancer: the dawn of a new treatment? 147
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 145
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 145
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 144
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 144
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 144
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 143
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 142
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 142
Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam 141
Helicobacter pylori and extragastric diseases: A review 141
Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study 140
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 139
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis 139
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 138
Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: A post hoc patient-tailored analysis of the "BE-FIT-IBD" study 138
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 136
Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey from the Italian society of endoscopic surgery and new technologies (SICE), the Italian society of digestive endoscopy (SIED), the world society of emergency surgery-Italy chapter (WSESit), and the Italian society of surgical endoscopy and digestive diseases (ISSE) 135
Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments 134
The burden of anaemia in patients with inflammatory bowel diseases 134
Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report 133
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 133
Telaprevir- or boceprevir-based triple-therapy in patients with HCV infection genotype 1: on-treatment efficacy and data on safety 133
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 133
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 132
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 132
Extra-Gastric Manifestations of Helicobacter pylori Infection 132
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 132
Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. 131
Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. 131
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 130
Impact of Helicobacter pylori Eradication on Inflammatory Bowel Disease Onset and Disease Activity: To Eradicate or Not to Eradicate? 128
Peptide Hp(2–20) accelerates healing of TNBS-induced colitis in the rat 128
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 127
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 127
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 126
Cyclic vomiting in a young patient with superior mesenteric artery syndrome 126
Cutaneous Kaposi's Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding 125
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 125
Totale 15.573
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022722 0 0 0 33 200 9 53 24 35 45 116 207
2022/20231.726 138 58 30 158 201 129 11 114 800 21 35 31
2023/2024932 57 38 43 64 240 113 28 17 7 40 96 189
2024/20253.154 20 46 83 138 503 430 414 243 450 347 259 221
2025/202612.975 529 734 685 569 1.036 6.787 799 644 402 310 314 166
2026/20272.720 149 388 1.035 1.148 0 0 0 0 0 0 0 0
Totale 24.154